Novartis announces FDA and EMA filing acceptance of ofatumumab, for treatment of relapsing form of MS Medical Dialogues Bureau25 Feb 2020 1:03 PM IST"With ofatumumab, we underpin our relentless dedication to reimagining medicine for patients across the MS spectrum and will work closely with the...
Biogen, Alkermes get USFDA nod for multiple sclerosis drug Vumerity Medical Dialogues Bureau31 Oct 2019 9:25 AM ISTThe new drug, Vumerity, was approved to treat relapsing forms of multiple sclerosis, a disabling autoimmune disease that damages the central nervous...
Roche touts drugs pipeline, rules out Merger and Acquisition just to boost sales Medical Dialogues Bureau7 Sept 2019 9:15 AM ISTRoche has twice upgraded 2019 sales forecasts, the latest time to mid- to high-single-digit percentage rate growth, as medicines including Ocrevus for...
Novartis, Lonza strengthen biosimilars push with MS, arthritis drug deals Medical Dialogues Bureau3 Sept 2019 9:30 AM ISTNovartis's Sandoz generics unit, among the biggest biosimilars makers, on Tuesday, agreed to license from Poland's Polpharma Biologics a version of...
Dilip Shanghvi plans comeback; Sun Pharma to develop its own medicines: Report Meghna A Singhania26 May 2019 6:13 PM ISTShanghvi estimates that Sun Pharma has invested about $1 billion in its patented-drug programme so far. He says growth in the Indian generics...
Alembic Pharma gets USFDA nod toTeriflunomide tablets, Tobramycin ophthalmic solution Farhat Nasim22 April 2019 11:55 AM ISTTeriflunomide tablets are indicated for the treatment of patients with relapsing forms of multiple sclerosis while Tobramycin ophthalmic solution is a...
Currency headwinds quell drug gains in Q4; says Merck KGaA Garima10 March 2019 8:59 AM ISTFRANKFURT: Germany's Merck KGaA posted a 1.3 per cent decline in adjusted core earnings in the fourth quarter as negative currency effects more than...
FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients Medical Dialogues Bureau12 May 2018 12:00 PM ISTThe U.S. Food and Drug Administration today approved Gilenya (fingolimod) to treat relapsing multiple sclerosis (MS) in children and adolescents age...
Roche stock up 12 billion dollars on cancer, hemophilia trials; rivals hit Ruby Khatun Khatun22 Nov 2017 10:00 AM ISTZURICH: Roche shares were lifted on Monday by two trial wins for its new cancer and hemophilia drugs, potential blockbusters that the Swiss drugmaker...
Roche MS drug Ocrevus wins European panel backing Ruby Khatun Khatun13 Nov 2017 10:02 AM ISTZURICH: Swiss drugmaker Roche on Friday won a key European panel's recommendation for its multiple sclerosis drug Ocrevus, which is on track for...
Mallinckrodt dives as sales of main drug Acthar disappoint Ruby Khatun Khatun9 Nov 2017 9:37 AM ISTShares of Mallinckrodt Plc plunged more than 30 percent to an all-time low on Tuesday after the drugmaker reported disappointing quarterly revenue and...
Natco pharma partner Mylan gets USFDA nod for multiple sclerosis injection Ruby Khatun Khatun4 Oct 2017 10:55 AM ISTNew Delhi: The US Food and Drug Administration has granted approval to drug major Natco Pharma's marketing partner Mylan's Glatiramer Acetate...
